Peter Hotez

Houston

Texas Medical Center (TMC) Professor-Vaccine Scientist-Author; Member, Philosophical Society of Texas and TAMEST; Dallas Morning News Texan of the Year 2022

Featured in: Favicon

cnn.com (+1) Favicon

medium.com Favicon

nih.gov (+1) Favicon

nytimes.com Favicon

dailymail.co.uk Favicon

foxnews.com Favicon

huffpost.com Favicon

nature.com Favicon

washingtonpost.com Favicon

telegraph.co.uk + 93 more

Articles

Science Under Siege

1 month ago | netgalley.com | Michael Mann |Peter Hotez

This is a great book. It was highly informative and, at the same time, chilling, as we are seeing in real-time the effects of science under siege. The book is well-paced and written in a conversational tone. Hotez and Mann pull no punches; their message is direct and blunt. And they make suggestions for action, many of which they are already doing and leading by example. This book is a must-read for anyone concerned about the future of science in America and elsewhere.
Measles, Mumps, Rubella Immunization and the Resurgence of Measles in America

1 month ago | acpjournals.org | Peter Hotez

As a very large and deadly measles epidemic spreads across 4 states in the Great Plains region of the United States, there are concerns that transmission of the measles virus will continue for months. The United States might even lose its measles elimination status if virus transmission persists for 12 months or longer (1). Ironically, this criterion was established by the Centers for Disease Control and Prevention (CDC) after the United States first achieved this hard-fought goal in 2000.
The Truth About … the Misinformation Fueling the Measles Outbreak

2 months ago | bakerinstitute.org | Peter Hotez |David Satterfield

“We need higher visibility as scientists. … We’re struggling over major revisions of papers and submitting grants and scientific meetings, and we’re basically invisible by that. And part of it is also the fault of our university leaders, especially at academic health centers, who are so worried about protecting the brand of the institution that they really don’t want their scientists and docs speaking out. That creates a vacuum.
Navigating your US bioscience career into the 2030s

Mar 28, 2025 | journals.plos.org | Peter Hotez

The pursuit of a meaningful and productive doctoral degree and career in bioscience hasn’t been easy of late. New findings point to: (1) the excessive time it takes to complete doctoral studies—with time-to-degree estimates of 5–7 years; (2) prolonged postdoctoral training or delayed opportunities for independent careers; and (3) limited numbers of academic research positions relative to the supply of PhD-trained scientists [1].
Revisiting What Constitutes a Neglected Tropical Disease?

Mar 17, 2025 | digitalcommons.library.tmc.edu | Paul J. Brindley |Peter Hotez |Shaden Kamhawi

KeywordsNeglected Diseases, Humans, Tropical Medicine, Poverty, Quality of LifeAbstractPLOS Neglected Tropical Diseases (PLOS NTDs) publishes research devoted to pathogenesis and other clinical aspects, epidemiology, prevention, diagnosis, treatment, and control of the neglected tropical diseases (NTDs), as well as work relevant to public health policy.
COVID-19 Vaccines and the Pandemic: Lessons Learnt for Other Neglected Diseases and Future Threats

Mar 17, 2025 | digitalcommons.library.tmc.edu | Peter Hotez |Sarah Gilbert |Melanie Saville |Lois Privor-Dumm

KeywordsHumans, COVID-19 Vaccines, Influenza, Human, Influenza Vaccines, Pandemics, COVID-19, Hemorrhagic Fever, Ebola, Neglected Diseases, COVID-19, Vaccines, Immunisation, Prevention strategiesAbstractThrough the experiences gained by accelerating new vaccines for both Ebola virus infection and COVID-19 in a public health emergency, vaccine development has benefited from a 'multiple shots on goal' approach to new vaccine targets.
"Global Regulatory Reforms To Promote Equitable Vaccine Access in the N" by Richard Mahoney, Peter J Hotez et al.

Mar 17, 2025 | digitalcommons.library.tmc.edu | Richard Mahoney |Peter Hotez |Maria Elena Bottazzi

AbstractThere is broad consensus that the global response to the Covid-19 pandemic was inadequate, leading to unacceptable levels of avoidable morbidity and mortality.
A Journey in Science: Molecular Vaccines for Global Child Health in Troubled Times of Anti-Science

Mar 17, 2025 | digitalcommons.library.tmc.edu | Peter Hotez

KeywordsChild, Humans, Child Health, COVID-19 Vaccines, Global Health, Hookworm Infections, Vaccines, SyntheticAbstractMy scientific life in translational medicine runs in two parallel, yet often converging paths. The first, is four-decade-long commitment to develop new vaccines for parasitic and neglected tropical diseases, as well as pandemic threats.
SARS-CoV-2 Variants Offer a Second Chance To Fix Vaccine Inequities

Mar 17, 2025 | digitalcommons.library.tmc.edu | Peter Hotez

KeywordsHumans, SARS-CoV-2, COVID-19, Antibodies, Neutralizing, Antibodies, Viral, Public health, Infectious diseases, Vaccines, SARS-CoV-2AbstractGlobal COVID-19 vaccine equity remains aspirational for much of the world. But the emergence of rapidly evolving SARS-CoV-2 variants provides new opportunities to correct past public policies, support local vaccine production and combat rising anti-vaccine aggression.
Vaccine Access, Equity and Justice: COVID-19 Vaccines and Vaccination

Mar 10, 2025 | digitalcommons.library.tmc.edu | Lois Privor-Dumm |Jean-Louis Excler |Sarah Gilbert |Peter Hotez

Publication Date6-1-2023JournalBMJ Global HealthDOI10.1136/bmjgh-2023-011881PubMedCentral® Posted Date6-8-2023PubMedCentral® Full Text VersionPost-printPublished Open-AccessyesKeywordsHumans, COVID-19 Vaccines, COVID-19, Vaccination, Vaccines, Social Justice, COVID-19, Immunisation, Public Health, Prevention strategiesAbstractAlthough significant progress has been made in achieving goals for COVID-19 vaccine access, the quest for equity and justice remains an unfinished agenda.